Compare Emerson Electric Co. (EMR) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Emerson Electric Co. vs GeneDx Holdings Corp — how do they compare? Emerson Electric Co. trades at $137.81 (market cap $76.31B), while GeneDx Holdings Corp trades at $63.19 (market cap $1.96B). The key difference: Emerson Electric Co. is far larger — about 38.9× GeneDx Holdings Corp's market cap, and Emerson Electric Co. pays a 1.63% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| EMR | WGS | |
|---|---|---|
Market Cap | $76.31B | $1.96B |
Sector | Industrials | Technology |
52-Week High | $161.69 | $167.51 |
52-Week Low | $123.30 | $34.51 |
Enterprise Value | $88.58B | $1.96B |
Dividend Yield | 1.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Emerson Electric (EMR) trades at $137.06, up 0.7% on the day, with a bearish technical signal but strong analyst support. Recent earnings have mostly beaten expectations, with Q2 2026 results pending. The company maintains solid profitability with a 13.35% net income margin and a consensus price target of $157.60, suggesting 15% upside. Cash flow trends show operational strength despite net outflows, and a dividend of $0.56 was recently declared.
EMR presents a mixed outlook: bullish fundamentals and analyst ratings contrast with near-term technical weakness. Investment appeal hinges on earnings execution and sector momentum, while risks include debt levels and market volatility. The stock's valuation at a P/E of 31.54 requires sustained growth to justify further gains.
GeneDx Holdings Corp. (WGS) trades at $65.785, up 5.37% today, but faces a bearish technical signal with the stock near resistance at $65. The company shows mixed fundamentals with strong revenue growth to $427.54M in 2025 but a net loss of -$21.02M, while analyst consensus remains bullish with a $75.40 price target. Recent news highlights multiple class-action lawsuits alleging securities fraud tied to a 49% stock decline and acquisition underperformance, creating significant investor uncertainty.
The outlook is highly conflicted: strong analyst buy ratings and recent earnings beats contrast with deepening losses, negative cash flow projections for 2026, and legal overhangs. Key risks include litigation outcomes, profitability challenges, and execution missteps, but the stock offers potential upside if the company can stabilize margins and resolve legal issues amid high institutional skepticism.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Emerson Electric Co.
Emerson Electric is a multi-industrial conglomerate that operates under two business platforms: automation solutions and commercial and residential solutions. The latter is further subdivided into two operating segments: climate technologies, which sells HVAC and refrigeration products and services as well as tools and home products, which sells tools and compressors, among other products and services. Commercial and residential solutions boasts several household brands, including Copeland and RIDGID. Automation solutions is most known for its process manufacturing solutions, which consists of measurement instrumentation, as well as valves and actuators, among other products and services. Roughly half of the firm's geographic sales take place in the United States.
Read more on EMR →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
